Women ages 18-54 were more likely than men to die after a first heart attack, according to a new study in the Go Red for Women spotlight issue of the Journal of the American Heart Association From 2011 to 2022, data analysis showed a significant increase in deaths...
The January 2026 research roundup covers several medical studies. One study examined the effectiveness of tranexamic acid for patients with minor traumatic injuries. It found no significant reduction in major bleeding, mortality, or the need for blood transfusions...
Targets to reduce salt in baguettes and other breads in France and pre-packaged foods in the U.K. could lead to significant improvements in preventing cardiovascular disease and reducing deaths, according to two new studies published in the Hypertension journalA study...
The American Heart Association offers some important information for staying heart healthy in cold temperaturesThe content broadly refers to the many hazards associated with cold temperatures that require preparation for upcoming winter storms.DALLAS, Jan. 23, 2026 —...
Ketamine for Seizures: Antiepileptic Action ExplainedKetamine is considered a potential treatment for refractory status epilepticus, RSE, and super-refractory status epilepticus, SRSE, conditions where seizures persist despite standard medications. Initial treatment...
Heart disease and stroke still top the list of leading causes of death in the U.S., according to the American Heart Association’s 2026 Heart Disease and Stroke Statistics UpdateAccording to the American Heart Association’s 2026 Heart Disease and Stroke Statistics...
While an analysis of scripted TV programs mischaracterizes who is likely to need CPR and where, TV characters were more likely to receive CPR than their real-life counterparts, finds a new study in Circulation: Population Health and Outcomes journal Scripted U.S. TV...
Vernakalant is an intravenous antiarrhythmic drug used for rapid conversion of recent onset atrial fibrillation to sinus rhythm. It is a class III antiarrhythmic that preferentially acts on atrial tissue. Its mechanism involves blocking multiple potassium channels,...
Ketamine vs Etomidate for RSIThe RSI trial investigated the use of ketamine versus etomidate as induction agents for rapid sequence intubation in critically ill adults. This was a prospective, multicenter, randomized, open-label, non-inferiority trial conducted in...
